We are live on ! Find out more
MDT icon

Medtronic

2,077 hedge funds and large institutions have $95.7B invested in Medtronic in 2024 Q1 according to their latest regulatory filings, with 139 funds opening new positions, 931 increasing their positions, 733 reducing their positions, and 145 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 931 | Existing positions reduced: 733

18% more capital inflows, than outflows

Capital inflows: $4.19B | Capital outflows: $3.56B

0.73% more ownership

Funds ownership: 82.01% → 82.74% (+0.73%)

0% more funds holding

Funds holding: 2,076 → 2,077 (+1)

4% less first-time investments, than exits

New positions opened: 139 | Existing positions closed: 145

3% less funds holding in top 10

Funds holding in top 10: 32 → 31 (-1)

17% less call options, than puts

Call options by funds: $643M | Put options by funds: $778M

Holders
2,077
Holders Change
+1
Holders Change %
+0.05%
% of All Funds
29.82%
Holding in Top 10
31
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-3.13%
% of All Funds
0.45%
New
139
Increased
931
Reduced
733
Closed
145
Calls
$643​M
Puts
$778​M
Net Calls
-⁠$135​M
Net Calls Change
-⁠$175​M

MDT Hedge Fund Activity: Q1 2024 in Review

2,077 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2024, worth a combined $95.7B — up 6.5% from $89.8B a quarter earlier.

Sellers outnumbered buyers: 145 funds closed out of MDT and 139 opened new positions — a net loss of 6 holders — while 733 trimmed existing stakes and 931 added.

The largest buyer was JP Morgan Chase, adding an estimated $533M. The largest seller was Wells Fargo, cutting an estimated $440M.

  • 2,077 institutional investors held Medtronic (MDT) as of Q1 2024, up from 2,076 in Q4 2023.
  • Funds reported $95.7B of Medtronic stock for Q1 2024, up 6.5% quarter-over-quarter.
  • 139 funds opened new Medtronic positions in Q1 2024 and 145 closed out, a net change of -6 holders.
  • The largest Medtronic buyer in Q1 2024 was JP Morgan Chase, an estimated $533M added.
  • The largest Medtronic seller in Q1 2024 was Wells Fargo, an estimated $440M sold.

Based on aggregated 13F filings for Q1 2024.